Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...

Bristol Myers Squibb in collaboration with Johnson & Johnson today announced the decision to stop the Phase 3 Librexia ACS trial evaluating the efficacy and safety of milvexian when added to the ...

Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up to 24 hours after onset) – a population with no approved drug options. Scp776 was safe and ...

RESEARCH TRIANGLE, N.C., Oct. 22, 2025 /PRNewswire/ -- Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapy for acute ischemic ...

The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, China The final, formatted version of the article will be published soon. Background: Stroke is a leading global cause of ...

Methods —Polyamines were measured in 16 patients with focal cerebral ischemia and in 8 healthy control subjects. Blood samples for polyamine measurement were taken at admission and at fixed time ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Fox News Digital interviewed Spencer Coursen, a threat management specialist and former U.S. Army Ranger & Special Deputy Marshal, about the U.S. Coast Guard’s Operation Pacific Viper. Senate ...

Lili Vachon said doctors rang her two weeks later to say 'oh by the way, you've had a stroke' A teacher who had a stroke at the age of 26 says hospital doctors were "convinced that it was a migraine" ...

Neutrophils infiltrate the ischemic brain. Here, the authors show a disease-stage dependent neutrophil diversification in neonatal brain injury; neutrophils aggravating tissue damage in the acute ...